Adult Health I Valencia Community College - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Adult Health I Valencia Community College

Description:

Arteriosclerosis thickening or hardening of the arterial wall ... CXR, IVP, arteriogram. EKG. Complications of HTN. Myocardial Infarction. Stroke (CVA) ... – PowerPoint PPT presentation

Number of Views:152
Avg rating:3.0/5.0
Slides: 32
Provided by: llor
Category:

less

Transcript and Presenter's Notes

Title: Adult Health I Valencia Community College


1
Adult Health IValencia Community College
  • Cardiovascular System
  • Atherosclerosis
  • Hypertension
  • Developed by
  • Leslie S. Lorette, RN, MSN

2
Atherosclerosis
  • Arteriosclerosis thickening or hardening of the
    arterial wall
  • Atherosclerosis a type of arteriosclerosis,
    involves plaque formation within the arterial
    wall
  • Most common cause of arterial obstruction
  • High incidence of Hypertension

3
Pathophysiology
  • Etiology unknown
  • Theories
  • Platelet aggregation
  • Lipid hypothesis
  • Combination of both theories

4
Factors Causing Arterial Injury
  • Intimal Injury
  • Mechanical injury
  • Hypertension
  • Chemical injury
  • ? levels of low density lipoproteins (LDL)
  • ? levels of high density lipoproteins (HDL)
  • ? levels toxins in bloodstream

5
Incidence Prevalence
  • Peripheral Atherosclerosis
  • 5 of Americans gt 60 YOA
  • 25 of Americans gt 75 YOA
  • Men vs. Women
  • CAD less common in premenopausal women,
    postmenopausal, equal with men
  • ? incidence in U.S. than other industrialized
    nations

6
Assessment
  • Vital Signs
  • BP in both arms
  • Palpate pulses
  • Skin temperature, capillary refill
  • Auscultate for bruits in larger arteries

7
Laboratory
  • Cholesterol
  • lt 200 mg/dL
  • High density lipoprotein (HDL)
  • Low or normal level indicates ? risk for
    atherosclerosis
  • Desirable level gt 35 mg/dL
  • Low density lipoprotein (LDL)
  • ? indicates increased risk for atherosclerosis
  • Desirable level lt 100 mg/dL

8
  • Triglycerides
  • ? with atherosclerosis
  • gt 200 mg/dL indicates hypertriglyceridema
  • Homocysteine
  • Essential sulfur containing amino acid derived
    from dietary protein
  • ? levels indicates ? risk for premature
    development of PVD and CAD (gt 15 µmo/L)
  • Folic acid 1 mg/day can ? level ? risk

9
Complications
10
Interventions
  • Diet Therapy
  • ? fat cholesterol intake
  • ? fruits, vegetables, whole grains, unsaturated
    fats
  • Smoking Cessation
  • Exercise
  • Drug Therapy
  • Lipitor, Zocor, Mevacor
  • Questran
  • Niacin

11
Hypertension
12
  • Blood Pressure
  • Tension or pressure exerted by blood against
    arterial walls
  • Hypertension (HTN or HTP)
  • Excess pressure in arterial portion of systemic
    circulation

13
Types of Hypertension
  • Essential HTN
  • 90 of all cases
  • No known cause
  • Factors associated
  • Family history
  • ? Na intake
  • ? calorie intake
  • ? alcohol intake
  • ? K intake
  • Secondary HTN
  • Renal Disease
  • Primary aldosteronism
  • Pheochromocytoma
  • Cushings Disease
  • Coarctation of Aorta
  • Brain Tumors
  • Pregnancy
  • Medication

14
Regulation of Blood Pressure
  • Renin-Angiotensin- Aldosterone System
  • Vasoconstrictor
  • Inhibit Sodium excretion
  • ? PVR (Essential HTN)
  • Atrial Natriuretic Peptide
  • Vasodilation
  • Salt water excretion
  • Epinephrine Norepinephrine
  • Arterial Baroreceptors
  • Carotid Sinus
  • Mean Arterial Pressure
  • Regulation of Body Fluid Volume
  • Vasopressin
  • Antidiuretic hormone
  • Salt water excretion

15
Incidence/Prevalence
  • 50 million Americans, 1 in 4 adults
  • ? incidence in African Americans
  • ? incidence in southeastern US
  • ? mortality with ? age

16
Assessment
  • Manifestations
  • Early no symptoms
  • Later vague symptoms
  • headache near back of head and neck
  • nocturia, confusion, nausea, vomiting, visual
    disturbances
  • Eye Examination
  • narrowed arterioles, hemorrhages, papilledema
  • Laboratory
  • None for essential HTN
  • Radiographic
  • None for diagnosis
  • CXR, IVP, arteriogram
  • EKG

17
Complications of HTN
  • Myocardial Infarction
  • Stroke (CVA)
  • Peripheral Vascular Disease
  • Renal Failure
  • Malignant HTN

18
Malignant HTN
  • Rapid ? in BP (syst. gt 200 diast. gt120)
  • c/o morning HA, confusion, restlessness, blurred
    vision, papilledema, dyspnea
  • Requires immediate treatment
  • Treatment goal
  • ? BP no gt 25 wining minutes to 2 hours, ?
    160/100 within 2-6 hours
  • Sodium nitroprusside (Nipride)
  • Continuous BP monitoring

19
Treatment
  • Education
  • Life Style Modification
  • Na restriction
  • Weight reduction
  • DASH diet
  • Moderation in alcohol intake
  • Exercise
  • Relaxation Techniques
  • Smoking Cessation

20
Figure 33.2 Sites of antihypertensive drug action
21
Drug Therapy
  • Recommended initial therapy
  • Single Drug, once-a-day
  • Start with diuretic or beta-blocker
  • ACE inhibitor for clients with diabetes or have
    HF or history of MI
  • Considerations for selection
  • Concurrent conditions
  • Quality of life
  • Cost
  • Drug interactions
  • After 1-3 months, if no chg in BP, ? dose or
    substitute for different class of
    antihypertensive
  • After 1 yr of effective control ? ? dose or of
    medications

22
Medications
  • Diuretics
  • Prevent tubular reabsorption of sodium ? H?O
    sodium excretion ? blood volume
  • Thiazide (HCTZ)
  • Loop (Lasix)
  • K Sparing (Aldactone)
  • Nursing Precautions
  • Monitor K
  • Hypovolemia
  • Orthostatic hypotension
  • Weights

23
  • Alpha Adrenergic Blockers
  • Block alpha receptors in vascular smooth muscle
  • ? vasomotor tone vasoconstriction
  • Cardura, Minipress, Hytrin
  • Give 1st dose at HS
  • Assess BP apical pulse prior to administration

24
  • Beta-adrenergic Blocking Agents
  • Prevent beta-receptor stimulation in the heart ?
    ? HR C.O.
  • Tenormin, Corgard, Lopressor
  • Not used with hx of asthma or bronchospasm
  • Side Effects
  • Fatigue, weakness, depression, sexual
    dysfunction, sleep disturbances
  • Caution with Diabetes (? BS)
  • Monitor HR for bradycardia

25
  • Calcium Channel Blocker
  • Inhibit the flow of calcium ions across the cell
    membrane of vascular tissue cardiac cells ?
    relaxation of arterial smooth muscle, ? PVR
    through vasodilation
  • Norvasc, Verapamil, Cardizem
  • Give with caution if taking Digoxin or beta
    blocker
  • Side Effects- ?BP, constipation
  • Effective in older adults African Americans

26
  • ACE Inhibitors
  • Prevent conversion of Angio I to Angio II
    preventing vasoconstriction water/Na retention
  • Capoten, Vasotec, Prinivil, Zestril
  • Assess BP WBC prior to 1st dose
  • Give 1 hour prior to meal
  • Side Effects
  • Severe ? BP after 1st dose
  • Orthostatic Hypotension
  • Angioedema
  • Monitor renal function
  • Monitor K
  • Effective in young Caucasians

27
  • Angiotensin II Receptor Antagonists
  • Same effect as ACE inhibitor but act by blocking
    the effect of angio II on receptors
  • Cozaar, Diovan, Atacand, Avapro
  • Used alone or in combination
  • Substitute for ACE Inhibitors or patients with
    ?K levels
  • Orthostatic hypotension

28
  • Central Acting Sympatholytics
  • Stimulate ?? receptors in CNS to suppress
    sympathetic outflow to heart blood vessels
  • Catapres, Aldomet, Wytensin
  • Administer at HS
  • Convenient- 7 day patch (Catapres TTS)
  • Contraindications
  • Catapres in pregnancy
  • Aldomet in clients with active liver disease

29
  • Vasodilators
  • Relax vascular smooth muscle ? PVR
  • Loniten, Apresoline,
  • Used in combination with diuretic or beta-blocker
  • Not used in mgmt of chronic HTN
  • Side Effects
  • Reflex tachycardia
  • Fluid retention
  • Orthostatic hypotension

30
Nursing Diagnoses
  • Ineffective Health Maintenance
  • RF Noncompliance
  • Imbalanced Nutrition gt body requirements
  • Excess Fluid Volume

31
Home Care
  • Take active role in disease management
  • BP monitoring
  • Medication compliance
  • Life style modifications
  • Follow up appointments
Write a Comment
User Comments (0)
About PowerShow.com